New research reveals that genomic tests that determine the molecular subtype of a woman's breast cancer provide a more precise prognosis and... ...http://www.medindia.net/news/genomic-tests-at-jefferson-breast-care-center-improve-breast-cancer-treatment-selection-129306-1.htm
Ventana Medical Systems, Inc. (VMSI), a member of the Roche Group, has reported that the Ventana HER2/neu (4B5) Rabbit Monoclonal Primary Antibody... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=79304&sid=2
- Data Expand Support for Development of Diagnostic to Identify Patients With Biomarkers of Anti-Progestin and Anti-Estrogen Activity - - Bolster... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=13732
REDWOOD CITY, Calif., Dec. 14, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from three studies of its Oncotype... ...http://in.sys-con.com/node/2898225
NEW YORK--(BUSINESS WIRE)-- Enzo Biochem Inc. (NYSE:ENZ) and Flagship Biosciences LLC, of Boulder, CO, today announced a partnership in... ...http://www.asianhhm.com/press/pressrelease_archives.asp?PID=8921&title=Enzo-Biochem-and-Flagship-Biosciences-Partner-to-Provide-TissueBased-Companion-Diagnostics-Offering-Complete-Solution-for-In-Situ-Hybridization-Development-to-Pharmaceutical-Companies
Victory infra launch !!! New...